Cantor Fitzgerald Maintains Overweight on GH Research, Raises Price Target to $35
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
Cantor Fitzgerald analyst Charles Duncan maintains GH Research (NASDAQ:GHRS) with a Overweight and raises the price target from $25 to $35.
Cantor Fitzgerald analyst Charles Duncan maintains GH Research (NASDAQ:GHRS) with a Overweight and raises the price target from $25 to $35.